Your Trusted Partner in Advanced Nucleic Acid Solutions

Established in 2004, RiboBio stands at the forefront of nucleic acid technology and therapeutic development. Our dedication to scientific excellence drives breakthrough discoveries that advance global health and research.

Excellence Without Compromise: The RiboBio Standard

At RiboBio, we understand that groundbreaking research requires unwavering quality and reliability. Our commitment to integrity and scientific excellence ensures that every product and service consistently exceeds industry standards.

Partner with RiboBio to access proven expertise in nucleic acid technology and join a global community of scientists making breakthrough discoveries.

Core Capabilities

Premium Nucleic Acid Molecular Reagents

Advanced solutions for molecular research and development

Innovative Cellular Biology Solutions

Cutting-edge tools and methods for cellular research

Specialized Scientific Research Services

Comprehensive support for advanced scientific investigations

Full-spectrum CDMO Partnerships

For oligonucleotide-based therapeutics development and manufacturing

Integrated Cross-disciplinary Expertise

Unified approach combining multiple scientific disciplines

Proven Global Impact

Trusted by over 5,000 research institutions worldwide
Research contributions featured in 15,000+ SCI publications
Partnered with Nobel laureates’ laboratories and leading pharmaceutical companies
State-of-the-art cGMP manufacturing facilities
Advanced research and development center

Quality Assurance Excellence

Comprehensive GMP/GLP compliance
ISO 9001:2015 & ISO 13485:2016 certified quality management systems
Rigorous manufacturing standards
Complete regulatory documentation
Expert technical support available globally
Validated by international research institutions

Innovation Leadership

Pioneering oligonucleotide API manufacturing
Established and lead the Canton Nucleic Acid Forum, a premier scientific conference that connects over 2,000 global leaders and attendees in nucleic acid therapeutics. The forum drives collaborative innovation between academic researchers and industry pioneers, positioning us at the forefront of nucleic acid advancement